Disparities in use of implantable cardioverter-defibrillators: Moving beyond process measures to outcomes data

JAMA

Volumn 298, Issue 13, 2007, Pages 1564-1566

  Redberg, Rita F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; EDITORIAL; ETHNIC DIFFERENCE; HEALTH CARE SYSTEM; HEALTH STATUS; HEART CATHETERIZATION; HEART DEATH; HEART FAILURE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; CAUCASIAN; FEMALE; HEALTH CARE DELIVERY; MALE; NEGRO; NOTE; SEX RATIO; STATISTICS; SUDDEN DEATH; UNITED STATES; UTILIZATION REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DELIVERY OF HEALTH CARE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; SEX DISTRIBUTION; UNITED STATES;

EID: 34948851985     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.13.1564     Document Type: Editorial

References (15)

1. Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Smedley BD, Stith AY, Nelson AR, eds. Washington, DC: National Academies Press; 2002.
2. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med. 1994;120(7):559-566.
3. Jha AK, Fisher ES, Li Z, Orav EJ, Epstein AM. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005;353(7):683-691.
4. Redberg RF. Gender, race, and cardiac care: why the differences? J Am Coll Cardiol. 2005;46(10):1852-1854.
5. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-883.
6. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237.
7. Phurrough SE, Salive ME, Chin J, Baldwin JF. Coverage decision memorandum for implantable cardioverter defibrillators. December 2004. http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=139. Accessibility verified September 10, 2007.
8. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298(13):1517-1524.
9. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298(13):1525-1532.
10. Dhruva S, Redberg RF. Variations between clinical trial subjects and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med. In press.
11. Lee DS, Tu JV, Austin PC, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49(25):2408-2415.
12. McMaster University Faculty of Health Sciences Web site. Health utilities index: Centre for Health Economics and Policy Analysis (CHEPA), working paper 98-11. http://www-fhs.mcmaster.ca/hug/. Accessed September 12, 2007.
13. Noyes K, Corona E, Zwanziger J, et al. Health-related quality of life consequences of implantable cardioverter defibrillators. Med Care. 2007;45(5):377-385.
14. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353(14):1471-1480.
15. Boriani G. SEARCH-MI: Appropriate ICD therapy in real-world registry of post-MI patients. http://www.theheart.org/article/808585.do. Accessed September 3, 2007.